NASDAQ:SLGL Sol-Gel Technologies (SLGL) Stock Price, News & Analysis $69.90 +1.60 (+2.34%) As of 03:24 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsInsider TradesNews and TrendsOwnershipSEC FilingsShort Interest About Sol-Gel Technologies Stock (NASDAQ:SLGL) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Sol-Gel Technologies alerts:Sign Up Key Stats Today's Range$68.07▼$71.6750-Day Range$59.28▼$88.0052-Week Range$28.81▼$97.97Volume19,502 shsAverage Volume41,099 shsMarket Capitalization$228.57 millionP/E RatioN/ADividend YieldN/APrice Target$197.50Consensus RatingModerate Buy Company Overview Sol-Gel Technologies Ltd. (NASDAQ: SLGL) is an Israeli specialty pharmaceutical company focused on developing and commercializing topical dermatological treatments. The company uses proprietary silica-based microsponge technology designed to encapsulate and gradually release active pharmaceutical ingredients in the skin. Its marketed products include TWYNEO, a topical cream combining tretinoin and benzoyl peroxide for the treatment of acne vulgaris, and EPSOLAY, a topical benzoyl peroxide cream for the treatment of inflammatory lesions associated with rosacea. Both products have received approval from the U.S. Food and Drug Administration. Sol-Gel Technologies is headquartered in Ness Ziona, Israel, and has focused primarily on the U.S. dermatology market through commercialization and licensing arrangements. The company was founded in 1997 and continues to develop additional topical therapies for dermatological conditions. Its leadership includes founder and Chief Executive Officer Dr. Alon Seri-Levy.AI Generated. May Contain Errors. Read More Sol-Gel Technologies Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks74th Percentile Overall ScoreSLGL MarketRank™: 3.687040923395 of 5 starsSol-Gel Technologies scored higher than 74% of companies evaluated by MarketBeat, and ranked 181st out of 873 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingModerate Buy Consensus RatingSol-Gel Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.71, and is based on 1 strong buy rating, 4 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialSol-Gel Technologies has a consensus price target of $197.50, representing about 184.6% upside from its current price of $69.40.Amount of Analyst CoverageSol-Gel Technologies has only been the subject of 3 research reports in the past 90 days.Read more about Sol-Gel Technologies' stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Sol-Gel Technologies are expected to grow in the coming year, from ($4.95) to ($4.93) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Sol-Gel Technologies is -12.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Sol-Gel Technologies is -12.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSol-Gel Technologies has a P/B Ratio of 8.47. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Sol-Gel Technologies' valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted15.50% of the float of Sol-Gel Technologies has been sold short.Short Interest Ratio / Days to CoverSol-Gel Technologies has a short interest ratio ("days to cover") of 2.96, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Sol-Gel Technologies has recently increased by 19.32%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSol-Gel Technologies does not currently pay a dividend.Dividend GrowthSol-Gel Technologies does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.91 News SentimentSol-Gel Technologies has a news sentiment score of 0.91. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.71 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 11 news articles for Sol-Gel Technologies this week, compared to 3 articles on an average week. Company Ownership3.9 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $3,684,739.00 in company stock, which represents 1.6237% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Sol-Gel Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $3,684,739.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders66.51% of the stock of Sol-Gel Technologies is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions26.18% of the stock of Sol-Gel Technologies is held by institutions.Read more about Sol-Gel Technologies' insider trading history. Receive SLGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sol-Gel Technologies and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SLGL Stock News HeadlinesHC Wainwright Analysts Increase Earnings Estimates for SLGLOctober 10, 2026 | americanbankingnews.comSol-Gel Technologies consensus price target decreased by 22.46% to $155.55October 2, 2026 | msn.comHere’s Why Trump Won’t End The Iran WarTrump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.October 14 at 1:00 AM | Banyan Hill Publishing (Ad)Sol-Gel Technologies Sets October 14 KOL Investor Day for SGT-610September 30, 2026 | tipranks.comSol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026September 30, 2026 | globenewswire.comSol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin SyndromeSeptember 17, 2026 | globenewswire.comSol-Gel Technologies (NASDAQ:SLGL) Major Shareholder Buys $98,448.42 in StockSeptember 15, 2026 | insidertrades.comSol-Gel Technologies: Phase 3 Gorlin Results Could Be The Next Major CatalystSeptember 10, 2026 | rttnews.comSee More Headlines SLGL Stock Analysis - Frequently Asked Questions How have SLGL shares performed this year? Sol-Gel Technologies' stock was trading at $42.14 at the beginning of 2026. Since then, SLGL shares have increased by 64.7% and is now trading at $69.40. How were Sol-Gel Technologies' earnings last quarter? Sol-Gel Technologies Ltd. (NASDAQ:SLGL) announced its earnings results on Friday, August, 21st. The company reported ($1.13) earnings per share for the quarter, beating analysts' consensus estimates of ($2.36) by $1.23. The firm had revenue of $0.59 million for the quarter, compared to the consensus estimate of $0.08 million. Sol-Gel Technologies had a negative trailing twelve-month return on equity of 44.05% and a negative net margin of 910.14%. When did Sol-Gel Technologies' stock split? Sol-Gel Technologies shares reverse split on the morning of Monday, May 5th 2025.The 1-10 reverse split was announced on Thursday, May 1st 2025. The number of shares owned by shareholders was adjusted after the closing bell on Friday, May 2nd 2025. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. When did Sol-Gel Technologies IPO? Sol-Gel Technologies (SLGL) raised $75 million in an IPO on Thursday, February 1st 2018. The company issued 6,250,000 shares at $11.00-$13.00 per share. Jefferies and BMO Capital Markets served as the underwriters for the IPO and JMP Securities and Raymond James were co-managers. How do I buy shares of Sol-Gel Technologies? Shares of SLGL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Sol-Gel Technologies own? Based on aggregate information from My MarketBeat watchlists, some other companies that Sol-Gel Technologies investors own include Micron Technology (MU), NVIDIA (NVDA), Advanced Micro Devices (AMD), Netflix (NFLX), General Motors (GM), Verizon Communications (VZ) and Walt Disney (DIS). Company Calendar Last Earnings8/21/2026Today10/14/2026KOL event10/14/2026Next Earnings (Estimated)11/19/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (17m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 SLGL's financial health is in the Green zone, according to TradeSmith. SLGL has been in this zone for over 17 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:SLGL CIK1684693 Webwww.sol-gel.com Phone(728) 931-3433Fax972-153-523044444Employees28Year Founded1997Price Target and Rating Average Price Target for Sol-Gel Technologies$197.50 High Price Target$285.00 Low Price Target$110.00 Potential Upside/Downside+182.5%Consensus RatingModerate Buy Rating Score (0-4)2.71 Research Coverage7 Analysts Profitability EPS (Trailing Twelve Months)($5.64) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$6.13 million Net Margins-910.14% Pretax Margin-910.14% Return on Equity-44.05% Return on Assets-36.96% Debt Debt-to-Equity RatioN/A Current Ratio10.37 Quick Ratio10.37 Sales & Book Value Annual Sales$19.39 million Price / Sales11.79 Cash FlowN/A Price / Cash FlowN/A Book Value$8.19 per share Price / Book8.53Miscellaneous Outstanding Shares3,270,000Free Float1,096,000Market Cap$228.57 million OptionableNo Data Beta1.14 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NASDAQ:SLGL) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersMicroscopic footage reveals immune cells destroying cancer cellsTime-lapse footage from a recent clinical study shows Natural Killer cells attacking and eliminating cancer ce...Market Tactic | SponsoredElon pays this company. Every time.Every Tesla built since 2012 pays this small, overlooked supplier a fee for its technology. So does every Star...Behind the Markets | SponsoredElon will prove them wrong againElon Musk's critics said self-driving cars were a pipe dream. Today, Tesla robotaxis carry passengers with no ...Paradigm Press | SponsoredA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredDid you grab your copy yet?Bill Poulos's Top 10 Stocks to Buy This Quarter report is still available free, but not for long. Every quarte...Profits Run | SponsoredMy next big call (under $1)17,556% on KDA. Here's what I'm buying now. It's a coin under $1.00 that most investors have never heard of...Crypto 101 Media | SponsoredIf you think you’re late to AI, see this nowTech leaders like Microsoft's Satya Nadella and Goldman Sachs' David Solomon say AI's infrastructure buildout ...Weiss Ratings | SponsoredBuffett's Final Warning: "The Dollar Is Going to Hell"Do not buy another AI stock until you've seen the arithmetic below. Nvidia is worth about $5.5 trillion. Al...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sol-Gel Technologies Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sol-Gel Technologies With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
